Literature DB >> 17905939

The role of dead-end in germ-cell tumor development.

Rui Zhu1, Chitralekha Bhattacharya, Angabin Matin.   

Abstract

Testicular germ-cell tumors occur in human males of all age groups, from infants to men over 50 years old. Most commonly, germ-cell tumors (generally known as testicular cancer) occur in young males between the ages of 15 to 35 years. The tumor tissues are usually histologically diverse, and testicular tumors that occur in the different age groups tend to be of specific histological subtypes. Most germ-cell tumors originate from primordial germ cells during embryonic development, although the progression and eventual detection of the disease occurs decades later in humans. Mouse strains spontaneously develop a specific subtype of testicular germ-cell tumors, the type I germ-cell tumors, and these tumors are similar to the germ-cell tumors (or teratomas) that occur in human infants. Some mouse strains, such as the 129-Ter strain, have extremely high germ-cell tumor incidences, making such strains ideal for genetic and biological studies of germ cell-tumor development. Here a brief overview of the recently identified genetic defect in the Ter strain, inactivation of the dead-end (Dnd1) gene, and the ongoing studies on Dnd1 to understand its role in germ-cell and germ cell-tumor development, are provided.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17905939      PMCID: PMC2518318          DOI: 10.1196/annals.1411.006

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  25 in total

1.  Experimental production of testicular teratomas in mice of strains 129, A/He, and their F1 hybrids.

Authors:  L C Stevens
Journal:  J Natl Cancer Inst       Date:  1970-04       Impact factor: 13.506

2.  Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors.

Authors:  D T Schneider; A E Schuster; M K Fritsch; J Hu; T Olson; S Lauer; U Göbel; E J Perlman
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

3.  Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours.

Authors:  E A Rapley; G P Crockford; D Teare; P Biggs; S Seal; R Barfoot; S Edwards; R Hamoudi; K Heimdal; S D Fossâ; K Tucker; J Donald; F Collins; M Friedlander; D Hogg; P Goss; A Heidenreich; W Ormiston; P A Daly; D Forman; T D Oliver; M Leahy; R Huddart; C S Cooper; J G Bodmer; D F Easton; M R Stratton; D T Bishop
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

4.  A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas.

Authors:  L C Stevens
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

5.  Primordial germ cell proliferation in fetal testes in mouse strains with high and low incidences of congenital testicular teratomas.

Authors:  T Noguchi; L C Stevens
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

6.  Origin of testicular teratomas from primordial germ cells in mice.

Authors:  L C Stevens
Journal:  J Natl Cancer Inst       Date:  1967-04       Impact factor: 13.506

7.  Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence.

Authors:  R I Skotheim; S M Kraggerud; S D Fosså; A E Stenwig; T Gedde-Dahl ; H E Danielsen; K S Jakobsen; R A Lothe
Journal:  Neoplasia       Date:  2001 May-Jun       Impact factor: 5.715

8.  Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

Authors:  A Mehta; M T Kinter; N E Sherman; D M Driscoll
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

9.  Characterization of gains, losses, and regional amplification in testicular germ cell tumor cell lines by comparative genomic hybridization.

Authors:  Octavian Henegariu; Nyla A Heerema; Virginia Thurston; Sin-Ho Jung; Martin Pera; Gail H Vance
Journal:  Cancer Genet Cytogenet       Date:  2004-01-01

10.  dead end, a novel vertebrate germ plasm component, is required for zebrafish primordial germ cell migration and survival.

Authors:  Gilbert Weidinger; Jürg Stebler; Krasimir Slanchev; Karin Dumstrei; Clare Wise; Robin Lovell-Badge; Christine Thisse; Bernard Thisse; Erez Raz
Journal:  Curr Biol       Date:  2003-08-19       Impact factor: 10.834

View more
  6 in total

1.  Screening for germline DND1 mutations in testicular cancer patients.

Authors:  Rolf H Sijmons; Yvonne J Vos; Johanna C Herkert; Krista K Bos; Martijn F Lutke Holzik; Josette E H M Hoekstra-Weebers; Robert M W Hofstra; Harald J Hoekstra
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

2.  Regulation of pluripotency in male germline stem cells by Dmrt1.

Authors:  Seiji Takashima; Michiko Hirose; Narumi Ogonuki; Miki Ebisuya; Kimiko Inoue; Mito Kanatsu-Shinohara; Takashi Tanaka; Eisuke Nishida; Atsuo Ogura; Takashi Shinohara
Journal:  Genes Dev       Date:  2013-09-12       Impact factor: 11.361

3.  Mouse dead end 1-β interacts with c-Jun and stimulates activator protein 1 transactivation.

Authors:  Yong Zhang; Yan-Lin Su; Le-Sai Li; Zhi Yang; Si Chen; Jie Xiong; Xiao-Hua Fu; Xiao-Ning Peng
Journal:  Mol Med Rep       Date:  2014-11-14       Impact factor: 2.952

4.  Maternal Dead-End1 is required for vegetal cortical microtubule assembly during Xenopus axis specification.

Authors:  Wenyan Mei; Zhigang Jin; Fangfang Lai; Tyler Schwend; Douglas W Houston; Mary Lou King; Jing Yang
Journal:  Development       Date:  2013-04-24       Impact factor: 6.862

5.  Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1).

Authors:  Chitralekha Bhattacharya; Sita Aggarwal; Madhu Kumar; Amatul Ali; Angabin Matin
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

6.  Pluripotent cell derivation from male germline cells by suppression of Dmrt1 and Trp53.

Authors:  Takashi Tanaka; Mito Kanatsu-Shinohara; Michiko Hirose; Atsuo Ogura; Takashi Shinohara
Journal:  J Reprod Dev       Date:  2015-07-27       Impact factor: 2.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.